Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Review
Tablet Binding: Causes, Analyses, and Strategic Avoidance
Shinichi Saito Takashi OsamuraKazunari YamashitaTadatsugu TaninoSatomi Onoue
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2025 Volume 73 Issue 12 Pages 1097-1105

Details
Abstract

The tablet is the most versatile dosage form in the pharmaceutical field due to its small size and excellent portability and ingestibility. Tablets are the most commonly used oral solid preparations, and are manufactured by compressing powders containing an active ingredient and excipients. In the manufacturing process, some materials from the tablet may adhere to the die wall, and tableting failures from damage due to binding may occur at the sides of the tablet. The definition and mechanisms of binding, the advantages of various assessment methods, and the current challenges and progress of assessment methods are comprehensively reviewed herein. Efforts to predict the risk of binding have been attempted using a multi-functional compaction instrument, tableting simulators, and simulations based on physicochemical parameters. Several analytical approaches have been applied as conventional evaluations for binding, such as visual observations of the tablet and die wall, measurements of ejection stress, differences between upper and lower punch forces, and die wall stress. However, these evaluation methods cannot always provide both qualitative and quantitative information and, thus, a more reliable evaluation strategy is desired. A newly-developed qualitative and quantitative evaluation method for powder adhesion to the die wall after tableting, named Binding Identification for Net Detriment (BIND), and its various applications to avoid binding are also reviewed herein. This review also focuses on the analytical performance and reliability of binding evaluations for commercial production.

Fullsize Image
Content from these authors
© 2025 The Author(s).
Published by The Pharmaceutical Society of Japan.

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
Previous article Next article
feedback
Top